1Quintiliani R, Cooper BW, Briceland LL, et al. Economic impact of streamlining antibiotic administration. Am J Med, 1987,82 : 391-394.
2Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med, 1995,155 : 1273-1276.
3Khan F, Karnik A. Clinical uses of sequential IV/PO ciprofloxacin vs ceftazidime in serious bacterial infections [ abstract 139]. Abstracts of the Ninth Mediterranean Congress on Chemother,Milan,Italy, 1994.
4Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med, 1991,91:462- 470.
6Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med, 2005, 118: 384- 392.
7Ramirez JA,Srinath L,Ahkee S,et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med, 1995,155 : 1273-1276.
9Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections : a risk factor for hospital mortality among critically ill patients. Chest, 1999,115:462-474.
10Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest, 2000, 118: 146-155.
6[28]Cunha BA.Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community acquired pneumonia [ J ].Am J Med,2001,111(5):412.
7[29]Ramirez JA,Bordon J.Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae [ J].Arch Intern Med,2001,161(6):848.
8[30]Castro-Guardiola A,Viejo-Rodriguez AL,Soler-Simon S,et al.Efficacy and safety of oral and early-swicth therapy for community-acquired pneumonia:a randomized controlled trial [ J ].Am J Med,2001,111(5):367.
9[31]Finch R,Schurmann D,Collins O,et al.Randomized controlled trial of sequential intravenous( i.v.)and oral moxifloxacin compared with sequential i.v.and oral co-amoxiclar with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.Antimicrob [ J ].Agents Chemother,2002,46( 6 ):1746.
